Metraipolis › archive › dc_f070d108aa4d

Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65… — Europe PMC PMID:41550694

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41550694
DOI
10.1093/ofid/ofaf817
License (as archived)
solo-consultazione
Archived
2026-11-07T01:05:15.015Z
SHA-256 of the archived text
a5197f044a5472292d03b0f24d8a657c69abacce42d23baf44da6d9ce1fbd6e2
Stable URL of this page
https://metraipolis.com/documento/dc_f070d108aa4d

How to cite

Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65… — Europe PMC PMID:41550694 — Europe PMC (en), https://europepmc.org/article/MED/41550694 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f070d108aa4d (Metraipolis archive dc_f070d108aa4d, sha256 a5197f044a5472292d03b0f24d8a657c69abacce42d23baf44da6d9ce1fbd6e2)
BibTeX
@misc{dcf070d108aa4d,
  title = {Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65… — Europe PMC PMID:41550694},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41550694},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f070d108aa4d; sha256 a5197f044a5472292d03b0f24d8a657c69abacce42d23baf44da6d9ce1fbd6e2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41550694. Agents can read the archived copy with the MCP tool read_document.